High-throughput label-free characterization of viable, necrotic and apoptotic human lymphoma cells in a coplanar-electrode microfluidic impedance chip.


Journal

Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289

Informations de publication

Date de publication:
15 Feb 2020
Historique:
received: 21 08 2019
revised: 12 11 2019
accepted: 14 11 2019
pubmed: 30 11 2019
medline: 18 11 2020
entrez: 30 11 2019
Statut: ppublish

Résumé

The study and the characterization of cell death mechanisms are fundamental in cell biology research. Traditional death/viability assays usually involve laborious sample preparation and expensive equipment or reagents. In this work, we use electrical impedance spectroscopy as a label-free methodology to characterize viable, necrotic and apoptotic human lymphoma U937 cells. A simple three-electrode coplanar layout is used in a differential measurement scheme and thousands of cells are measured at high-throughput (≈200 cell/s). Tailored signal processing enables accurate and robust cell characterization without the need for cell focusing systems. The results suggest that, at low frequency (0.5 MHz), signal magnitude enables the discrimination between viable/necrotic cells and cell fragments, whereas phase information allows discriminating between viable cells and necrotic cells. At higher frequency (10 MHz) two subpopulations of cell fragments are distinguished. This work substantiates the prominent role of electrical impedance spectroscopy for the development of next-generation cell viability assays.

Identifiants

pubmed: 31780405
pii: S0956-5663(19)30966-2
doi: 10.1016/j.bios.2019.111887
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111887

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Adele De Ninno (A)

Department of Civil Engineering and Computer Science, University of Rome Tor Vergata, 00133, Rome, Italy.

Riccardo Reale (R)

Department of Civil Engineering and Computer Science, University of Rome Tor Vergata, 00133, Rome, Italy.

Alessandro Giovinazzo (A)

Department of Experimental Medicine, University of Rome Tor Vergata, 00133, Rome, Italy.

Francesca R Bertani (FR)

Institute for Photonics and Nanotechnologies, Italian National Research Council, 00156, Rome, Italy.

Luca Businaro (L)

Institute for Photonics and Nanotechnologies, Italian National Research Council, 00156, Rome, Italy.

Paolo Bisegna (P)

Department of Civil Engineering and Computer Science, University of Rome Tor Vergata, 00133, Rome, Italy.

Claudia Matteucci (C)

Department of Experimental Medicine, University of Rome Tor Vergata, 00133, Rome, Italy.

Federica Caselli (F)

Department of Civil Engineering and Computer Science, University of Rome Tor Vergata, 00133, Rome, Italy. Electronic address: caselli@ing.uniroma2.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH